"World's Most Complete Market Research Reports Repository"

Global Finasteride Market Research Report 2011-2023

Summary
The global Finasteride market will reach xxx Million USD in 2018 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
1 mg Tablet
5 mg Tablet
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Medical Uses
Prostate Enlargement
Prostate Cancer
Scalp Hair Loss
Excessive Hair Growth
Transgender Women
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 1 mg Tablet
1.2.1.2 5 mg Tablet
1.2.2 by Application
1.2.2.1 Medical Uses
1.2.2.2 Prostate Enlargement
1.2.2.3 Prostate Cancer
1.2.2.4 Scalp Hair Loss
1.2.2.5 Excessive Hair Growth
1.2.2.6 Transgender Women
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 1 mg Tablet Market, 2011-2016
4.1.2 5 mg Tablet Market, 2011-2016
4.2 Market Forecast
4.2.1 1 mg Tablet Market Forecast, 2017-2022
4.2.2 5 mg Tablet Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Medical Uses Market, 2011-2016
5.1.2 Prostate Enlargement Market, 2011-2016
5.1.3 Prostate Cancer Market, 2011-2016
5.1.4 Scalp Hair Loss Market, 2011-2016
5.1.5 Excessive Hair Growth Market, 2011-2016
5.1.6 Transgender Women Market, 2011-2016
5.2 Market Forecast
5.2.1 Medical Uses Market Forecast, 2017-2022
5.2.2 Prostate Enlargement Market Forecast, 2017-2022
5.2.3 Prostate Cancer Market Forecast, 2017-2022
5.2.4 Scalp Hair Loss Market Forecast, 2017-2022
5.2.5 Excessive Hair Growth Market Forecast, 2017-2022
5.2.6 Transgender Women Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Merck
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Actavis
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Sandoz
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Teva Pharmaceuticals
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Cipla
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 RelonChem
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Dr. Reddy
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Accord Pharmaceuticals
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 Henan Topfond
8.9.1 Profile
8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.10 Zhejiang CONBA Pharmaceutical
8.10.1 Profile
8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.11 Shandong Renhetang Pharmaceutical
8.12 Guangdong Eashu Pharmacetical
9 Conclusion

Table Product Specifications of Finasteride
Table Products Segment of Finasteride
Table 1 mg Tablet Overview
Table 5 mg Tablet Overview
Table Global Finasteride Market by Type, 2011-2022 (USD Million)
Table Application Segment of Finasteride
Table Medical Uses Overview
Table Prostate Enlargement Overview
Table Prostate Cancer Overview
Table Scalp Hair Loss Overview
Table Excessive Hair Growth Overview
Table Transgender Women Overview
Table Global Finasteride Market by Application, 2011-2022 (USD Million)
Table Global Finasteride Market by Region, 2011-2022 (USD Million)
Table Cost of Finasteride
Table Market Dynamics
Table Policy of Finasteride
Table GDP of Major Countries
Table 1 mg Tablet CAGR by Revenue and Volume, 2011-2016
Table 5 mg Tablet CAGR by Revenue and Volume, 2011-2016
Table 1 mg Tablet CAGR by Revenue and Volume, 2012-2022
Table 5 mg Tablet CAGR by Revenue and Volume, 2012-2022
Table Medical Uses CAGR by Revenue and Volume, 2011-2016
Table Prostate Enlargement CAGR by Revenue and Volume, 2011-2016
Table Prostate Cancer CAGR by Revenue and Volume, 2011-2016
Table Scalp Hair Loss CAGR by Revenue and Volume, 2011-2016
Table Excessive Hair Growth CAGR by Revenue and Volume, 2011-2016
Table Transgender Women CAGR by Revenue and Volume, 2011-2016

Choose License Type